Flagship Pioneering — Activity | F4

Team Portfolio Raise Read Contact

F4/Flagship Pioneering/Activity

Flagship Pioneering Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Launched Serif Biomedicines with $50M in founding capital to develop modified DNA genetic medicines.

Serif Biomedicines

Serif Biomedicines Flagship Pioneering

biopharmadive.comAPR 21, 2026

flagshippioneering.com

APR 21, 2026

News

Announced an AWS collaboration to give Flagship companies cloud credits, technical support, and AI capabilities for life sciences innovation.

AWS collaboration

Flagship Pioneering

flagshippioneering.comAPR 1, 2026

APR 1, 2026

Exit

Portfolio company Generate:Biomedicines completed IPO on Nasdaq with $400M in proceeds.

Generate Biomedicines

Generate Biomedicines Flagship Pioneering

reuters.comFEB 27, 2026

FEB 27, 2026

Essay

Published Noubar Afeyan's 2026 annual letter arguing for renewed commitment to scientific research, biotechnology innovation, and AI-enabled discovery.

Choosing Science

Flagship Pioneering

flagshippioneering.comJAN 12, 2026

JAN 12, 2026

Essay

Noubar Afeyan's annual letter on the scientific method, biotech breakthroughs, and the importance of science-based policy.

Choosing Science - 2026 Annual Letter

Flagship Pioneering

flagshippioneering.comJAN 12, 2026

JAN 12, 2026

Investment

Unveiled Expedition Medicines with $50M in founding capital for AI-powered drug discovery platform.

Expedition Medicines

Expedition Medicines Flagship Pioneering

flagshippioneering.comOCT 2025

flagshippioneering.com

OCT 2025

Investment

Unveiled Extuitive with an initial $20M seed commitment to build AI-native product innovation and creative marketing tools.

Extuitive

Extuitive Flagship Pioneering

flagshippioneering.comSEP 18, 2025

SEP 18, 2025